Jamp Lamivudine / Zidovudine 300 mg (Zidovudine TABLET) 300 MG

JAMP Lamivudine/Zidovudine 300 mg tablets combine two antiretroviral drugs for HIV treatment. This oral medication is designed to manage HIV infection by reducing viral load. Learn more about its uses and effects.

Strength

300 MG

Manufacturer / TM Owner

JAMP PHARMA CORPORATION

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

JAMP Lamivudine/Zidovudine 300 mg tablets are used in the treatment of HIV infection. This combination therapy helps to control the virus and improve immune function. It is often prescribed as part of a broader antiretroviral regimen to manage HIV. What is Lamivudine/Zidovudine used for? Primarily, it aids in reducing the amount of HIV in the body, helping to slow the progression of the disease.

Side Effects

Common effects of JAMP Lamivudine/Zidovudine 300 mg tablets may include fatigue, headache, and nausea. Some individuals might experience dizziness or changes in mood. These effects vary and are not experienced by everyone. Always consult a healthcare provider for personalized advice.

Precautions & Warnings

Handle JAMP Lamivudine/Zidovudine 300 mg tablets with care, following the prescribed dosage and administration guidelines. Store in a cool, dry place away from direct sunlight. Keep out of reach of children and pets. Do not share this medication with others.

Avoid Interactions

JAMP Lamivudine/Zidovudine 300 mg tablets may interact with other medications, including certain antibiotics and antiretrovirals. Alcohol and other substances can also affect its efficacy. Always inform your healthcare provider about all medications and supplements you are taking.

Frequently Asked Questions

JAMP Lamivudine/Zidovudine 300 mg tablets are used to manage HIV infection by reducing the viral load in the body.

Take JAMP Lamivudine/Zidovudine 300 mg tablets orally, following the dosage and administration instructions provided by your healthcare provider.

Common side effects may include fatigue, headache, nausea, dizziness, and mood changes.

Alcohol may interact with JAMP Lamivudine/Zidovudine 300 mg tablets. Consult your healthcare provider for personalized advice.

Store JAMP Lamivudine/Zidovudine 300 mg tablets in a cool, dry place away from direct sunlight and out of reach of children and pets.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.